130 related articles for article (PubMed ID: 33914194)
1. Genetic polymorphisms in SCN2A are not associated with epilepsy risk and AEDs response: evidence from a meta-analysis.
Yang R; Qian R; Chen K; Yi W; Sima X
Neurol Sci; 2021 Jul; 42(7):2705-2711. PubMed ID: 33914194
[TBL] [Abstract][Full Text] [Related]
2. Association Between
Li M; Zhong R; Lu Y; Zhao Q; Li G; Lin W
Front Neurol; 2020; 11():591828. PubMed ID: 33519675
[No Abstract] [Full Text] [Related]
3. SCN1A, SCN2A and SCN3A gene polymorphisms and responsiveness to antiepileptic drugs: a multicenter cohort study and meta-analysis.
Haerian BS; Baum L; Kwan P; Tan HJ; Raymond AA; Mohamed Z
Pharmacogenomics; 2013 Jul; 14(10):1153-66. PubMed ID: 23859570
[TBL] [Abstract][Full Text] [Related]
4. SCN1A and SCN2A polymorphisms are associated with response to valproic acid in Chinese epilepsy patients.
Shi L; Zhu M; Li H; Wen Z; Chen X; Luo J; Lin C; Zhang Z
Eur J Clin Pharmacol; 2019 May; 75(5):655-663. PubMed ID: 30693367
[TBL] [Abstract][Full Text] [Related]
5. Effect of SCN1Aand SCN2A gene polymorphisms on the efficacy of valproic acid treatment in Chinese children with epilepsy.
Bao Z; Li H; Hu J; Zhao R; Yan L; Zheng A
PLoS One; 2024; 19(6):e0304869. PubMed ID: 38837984
[TBL] [Abstract][Full Text] [Related]
6. Role of SCN2A c.56G/A Gene Polymorphism in Egyptian Children with Genetic Epilepsy with Febrile Seizure Plus.
Berseem NF; Khattab ESAEH; Saad DS; Abd Elnaby SA
CNS Neurol Disord Drug Targets; 2022; 21(5):450-457. PubMed ID: 34607551
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms of ABAT, SCN2A and ALDH5A1 may affect valproic acid responses in the treatment of epilepsy in Chinese.
Li X; Zhang J; Wu X; Yan H; Zhang Y; He RH; Tang YJ; He YJ; Tan D; Mao XY; Yin JY; Liu ZQ; Zhou HH; Liu J
Pharmacogenomics; 2016 Dec; 17(18):2007-2014. PubMed ID: 27918244
[TBL] [Abstract][Full Text] [Related]
8. Lack of association of SCN2A rs17183814 polymorphism with the efficacy of lamotrigine monotherapy in patients with focal epilepsy from Herzegovina area, Bosnia and Herzegovina.
Pejanovic-Skobic N; Markovic I; Bozina N; Basic S
Epilepsy Res; 2019 Dec; 158():106221. PubMed ID: 31707316
[TBL] [Abstract][Full Text] [Related]
9. Effects of SCN1A and SCN2A polymorphisms on responsiveness to valproic acid monotherapy in epileptic children.
Liu M; Mao J; Xu H; Wang J; Zhao P; Xu Q; Du Z
Epilepsy Res; 2020 Dec; 168():106485. PubMed ID: 33096315
[TBL] [Abstract][Full Text] [Related]
10. Effects of SCN1A and SCN2A polymorphisms on responsiveness to valproic acid monotherapy in epileptic children: A protocol for systematic review and meta-analysis.
Wen Z; Chen J; Zhu B; Lu Y; Chen L
Medicine (Baltimore); 2021 May; 100(20):e25831. PubMed ID: 34011048
[TBL] [Abstract][Full Text] [Related]
11. Relationship between ABCB1 3435TT genotype and antiepileptic drugs resistance in Epilepsy: updated systematic review and meta-analysis.
Chouchi M; Kaabachi W; Klaa H; Tizaoui K; Turki IB; Hila L
BMC Neurol; 2017 Feb; 17(1):32. PubMed ID: 28202008
[TBL] [Abstract][Full Text] [Related]
12. ABCB1 C3435T polymorphism and the risk of resistance to antiepileptic drugs in epilepsy: a systematic review and meta-analysis.
Haerian BS; Roslan H; Raymond AA; Tan CT; Lim KS; Zulkifli SZ; Mohamed EH; Tan HJ; Mohamed Z
Seizure; 2010 Jul; 19(6):339-46. PubMed ID: 20605481
[TBL] [Abstract][Full Text] [Related]
13. Association of SCN1A, SCN2A and ABCC2 gene polymorphisms with the response to antiepileptic drugs in Chinese Han patients with epilepsy.
Ma CL; Wu XY; Zheng J; Wu ZY; Hong Z; Zhong MK
Pharmacogenomics; 2014 Jul; 15(10):1323-36. PubMed ID: 25155934
[TBL] [Abstract][Full Text] [Related]
14. Association between two SCN1A polymorphisms and resistance to sodium channel blocking AEDs: a meta-analysis.
Bao Y; Liu X; Xiao Z
Neurol Sci; 2018 Jun; 39(6):1065-1072. PubMed ID: 29582177
[TBL] [Abstract][Full Text] [Related]
15. A systematic review and meta-analysis of the association of ABCC2/ABCG2 polymorphisms with antiepileptic drug responses in epileptic patients.
Zan X; Yue G; Hao Y; Sima X
Epilepsy Res; 2021 Sep; 175():106678. PubMed ID: 34087576
[TBL] [Abstract][Full Text] [Related]
16. The ABCC2 c.-24C>T polymorphism increases the risk of resistance to antiepileptic drugs: A meta-analysis.
Qian L; Fang S; Yan YL; Zeng SS; Xu ZJ; Gong ZC
J Clin Neurosci; 2017 Mar; 37():6-14. PubMed ID: 27816260
[TBL] [Abstract][Full Text] [Related]
17. Association of sodium voltage-gated channel genes polymorphisms with epilepsy risk and prognosis in the Saudi population.
Alghamdi MA; Al-Eitan LN; Asiri A; Rababa'h DM; Alqahtani SA; Aldarami MS; Alsaeedi MA; Almuidh RS; Alzahrani AA; Sakah AH; El Nashar EM; Otaif MY; Abdel Ghaffar NF
Ann Med; 2022 Dec; 54(1):1938-1951. PubMed ID: 35801810
[TBL] [Abstract][Full Text] [Related]
18. Multidrug resistance in epilepsy and polymorphisms in the voltage-gated sodium channel genes SCN1A, SCN2A, and SCN3A: correlation among phenotype, genotype, and mRNA expression.
Kwan P; Poon WS; Ng HK; Kang DE; Wong V; Ng PW; Lui CH; Sin NC; Wong KS; Baum L
Pharmacogenet Genomics; 2008 Nov; 18(11):989-98. PubMed ID: 18784617
[TBL] [Abstract][Full Text] [Related]
19. The roles of variants in human multidrug resistance (MDR1) gene and their haplotypes on antiepileptic drugs response: a meta-analysis of 57 studies.
Li H; Wang B; Chang C; Wu M; Xu Y; Jiang Y
PLoS One; 2015; 10(3):e0122043. PubMed ID: 25816099
[TBL] [Abstract][Full Text] [Related]
20. Association of SCN1A, SCN2A, and UGT2B7 Polymorphisms with Responsiveness to Valproic Acid in the Treatment of Epilepsy.
Lu Y; Su Q; Li M; Dayimu A; Dai X; Wang Z; Che F; Xue F
Biomed Res Int; 2020; 2020():8096235. PubMed ID: 32185219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
